MOH — authorised 23 July 1975
- Marketing authorisation holder: BRISTOL MYERS SQUIBB
- Status: likely_approved
MOH authorised Estrace on 23 July 1975
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 23 July 1975.
BRISTOL MYERS SQUIBB holds the UAE marketing authorisation.